Arbitrating Pharma Disputes On The Rise – Planning Ahead Makes Sense
Executive Summary
Pharmaceutical companies risk coming up against complex and high value disputes in their everyday dealings and operations, and arbitration is increasingly being used to resolve these disputes. Lawyers Chris Parker and Elizabeth Reeves discuss the kinds of disputes pharmaceutical companies face, why international arbitration is well-suited to resolving such disputes, and what companies can do to plan ahead.